Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- GNT PHARMA
- Publication Date
- 2006-08-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to novel salicylic acid compounds, compositions, and methods for preventing and preventing neurological diseases accompanied by neuronal death. technical background
[0002] Excitotoxicity and Brain Disease
[0003] Hyperactivation of ionotropic glutamate receptors sensitive to N-methyl-D-aspartate (NMDA receptors) causes neuronal death and is known to mediate a variety of neurological disorders [Choi , Neuron 1:623-634 (1988)]. Glutamate is an excitatory neurotransmitter, which accumulates in large quantities in the brain and is susceptible to hypoxic-ischemic damage, which activates ionized glutamate receptors, making them accessible to calcium and sodium ions Infiltration, followed by neuronal death [Choi and Rothman, Annu Rev Neurosci: 13: 171-182 (1990)]. NMDA receptor antagonists significantly reduced hypoglycemia, hypoxia, and hypoxic-ischemia induced by brain injury [Simon, Swan, Griffiths, and Meldrum. Science...